RAD51 inhibitor (Satyarx)

N/A

Report date: 2025/01/26 16:57:09
NME

Base Information

Drug NameRAD51 inhibitor (Satyarx)
Drug Alias NameRAD51 inhibitor (Satyarx)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA repair protein RAD51 homolog 1 inhibitors
TargetsDNA repair protein RAD51 homolog 1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSatyarx Pharma Innovations Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSatyarx Pharma Innovations Pvt Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungOvarian NeoplasmsPancreatic Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A